Update: Alkem Laboratories has confirmed that the Income Tax Department is conducting a survey at some of its offices and subsidiaries. The firm said in an exchange filing that the development would have no impact on the company’s operations.
Shares of pharma major Alkem Laboratories were slipping on Thursday after reports suggested that the firm’s premises were allegedly being investigated by income tax authorities.
What Happened: A tweet on social media platform X by Hemant Ghai, news director of business news, Bharat Express News Network on Thursday, said that an income tax survey was currently being conducted at Alkem Laboratories.
Ghai also said that more details will be updated soon.
Alkem Laboratories is a generic and specialty pharmaceutical manufacturing company. It is the seventh-largest pharma company in India by market cap.
Get Ring The Bell, Benzinga India’s weekly briefing. Designed specifically for investors like you.
The firm’s most popular brands include Clavam, Pan, Pan-D and Taxim-O, and Alkem makes 29% of its revenue from offshore sales. The firm has 20 manufacturing facilities across India and the US and has a business footprint in over 40 countries.
Indian pharma companies’ exports have recently been under scrutiny from the U.S. Food and Drug Administration for lapses in drug manufacturing, with some of the country’s biggest names being pulled up by the drug regulation authority.
Price Action: Alkem Laboratories’ share price was down 1.57% at ₹1,839.15 in late afternoon trade on Thursday.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.